Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Dana-Farber Cancer Institute published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-1 of 1
» View all items
    Apr 28, 2008 |Story| Los Angeles Times

  1. Moles' split personality

    We've long been told to keep an eye on our moles lest they progress to melanoma, a form of skin cancer that's treatable if caught early, deadly if not. But not all moles are equal -- some are risky; others can be safely left alone. The biological roots of those differences are not really understood. However, scientists are making progress on several fronts.
    Special to the Los Angeles Times
    We've long been told to keep an eye on our moles lest they progress to melanoma, a form of skin cancer that's treatable if caught early, deadly if not. But not all moles are equal -- some are risky; others can be safely left alone. The biological roots of...

    Tags: Novartis AG, Bethesda (Montgomery, Maryland), Lymphatic System, David Fisher, Drugs and Medicines

Original site for Dana-Farber Cancer Institute topic gallery.
Advertisement